CompletedNot Applicable

Multidisciplinary Rehabilitation Program for Treatment-Resistant Psychotic Forensic Patients: A Comparative Study

Oman20 participantsStarted 2025-07-10

Plain-language summary

This study employs a quasi-experimental design to evaluate the effectiveness of a 6-month multidisciplinary rehabilitation program integrating psychodynamic group therapy, art therapy, music therapy, and cognitive stimulation compared to standard rehabilitation (physiotherapy and occupational therapy). It will be done between a group of a total of 20 patients are divided into an intervention group and a control group from the forensic psychiatric department in Al Masarra Hospital.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of chronic psychotic disorder (e.g., schizophrenia or schizoaffective disorder) confirmed by psychiatric assessment and medical records.
✓. Presence of residual psychotic symptoms (positive symptoms such as hallucinations, delusions; and/or negative symptoms such as blunted affect, social withdrawal) despite ongoing psychotropic treatment.
✓. Medically stable and deemed suitable for participation by the treating psychiatrist or healthcare team.
✓. Patients who provide informed consent to participate in the rehabilitation program and research study.

Exclusion criteria

✕. Acute medical or psychiatric conditions requiring immediate intervention.
✕. Developmental or intellectual disabilities that significantly impair participation in the rehabilitation program or assessments.
✕. Current substance dependence that would interfere with participation.
✕. Significant risk of harm to self or others, based on clinical assessment or history of violence/aggression.
✕. Contraindications to specific rehabilitation program components (e.g., physical exercise, group activities) as determined by medical evaluation.
✕. Inability to comprehend study requirements or provide informed consent due to language barriers, cognitive impairment, or other factors.

What they're measuring

Change in Psychotic Symptoms Measured by the Positive and Negative Syndrome Scale (PANSS)

Timeframe: Baseline (pre-intervention) and 6 months (post-intervention).

Trial details

NCT IDNCT07183982

SponsorOman Ministry of Health

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2025-07-10

View on ClinicalTrials.gov More Schizophenia Disorder trials